| Product Code: ETC7634734 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 Ireland Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Ireland Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for rapid and accurate diagnostic testing |
4.2.2 Growing prevalence of infectious diseases in Ireland |
4.2.3 Technological advancements in molecular point-of-care testing using NAAT |
4.3 Market Restraints |
4.3.1 High cost associated with molecular point-of-care testing technology |
4.3.2 Limited access to advanced healthcare facilities in some regions of Ireland |
4.3.3 Regulatory challenges and compliance requirements for NAAT testing |
5 Ireland Molecular Point of Care Testing (using NAAT) Market Trends |
6 Ireland Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 Ireland Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Ireland Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 Ireland Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 Ireland Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 Ireland Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 Ireland Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Adoption rate of molecular point-of-care testing in healthcare facilities |
8.2 Average turnaround time for test results |
8.3 Number of training programs and workshops conducted on NAAT technology |
8.4 Rate of reimbursement for molecular point-of-care testing services |
8.5 Percentage of healthcare professionals certified in NAAT testing techniques |
9 Ireland Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 Ireland Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Ireland Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 Ireland Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 Ireland Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here